Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
776,297
-
Shares change
-
+52,538
-
Total reported value, excl. options
-
$136,185,051
-
Value change
-
+$9,292,228
-
Put/Call ratio
-
25.7%
-
Number of buys
-
36
-
Number of sells
-
-36
-
Price
-
$175.44
Significant Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q1 2021
117 filings reported holding BBH - VANECK ETF TRUST - BIOTECH ETF as of Q1 2021.
VANECK ETF TRUST - BIOTECH ETF (BBH) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 776,297 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (119,442 shares), MORGAN STANLEY (63,935 shares), ROYAL BANK OF CANADA (51,982 shares), Kestra Advisory Services, LLC (42,095 shares), UBS Group AG (40,670 shares), MURPHY CAPITAL MANAGEMENT INC (33,948 shares), BANK OF AMERICA CORP /DE/ (33,407 shares), MOGY JOEL R INVESTMENT COUNSEL INC (27,837 shares), LPL Financial LLC (20,961 shares), and STIFEL FINANCIAL CORP (20,409 shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.